Skip to main content
CTOS 2024 Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Paper 44 - COMBINATION OF MDM2 AND CDK4/6 INHIIBITOR IN PATIENTS WITH ADVANCED WELL AND DE-DIFFERENCIATED LIPOSARCOMA AND OTHERS CANCERS: COHORT ANALYSIS FROM THE MEGAMOST PHASE II BASKET STUDY

Friday, November 15, 2024
9:00 AM – 10:00 AM PST
Location: Harbor Ballroom